Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.
Positive Phase 2 End of Study Data with Bel-sar in Early-Stage Choroidal Melanoma; Ongoing Phase 3 CoMpass Trial Recently Received Authorization to Start Enrolling Patients in Europe Multiple...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.74 | -15.9926470588 | 10.88 | 11.22 | 9.14 | 165338 | 10.19237518 | CS |
| 4 | -2.77 | -23.2577665827 | 11.91 | 11.99 | 9.14 | 183666 | 10.82255816 | CS |
| 12 | 1.43 | 18.5473411154 | 7.71 | 12.3782 | 7.26 | 173974 | 10.04486151 | CS |
| 26 | 1.9 | 26.2430939227 | 7.24 | 12.3782 | 6.63 | 173873 | 9.02640857 | CS |
| 52 | 0.97 | 11.8727050184 | 8.17 | 12.3782 | 6.63 | 171245 | 8.5375916 | CS |
| 156 | -14.69 | -61.6449853126 | 23.83 | 24.83 | 5.99 | 118820 | 10.52122206 | CS |
| 260 | -4.96 | -35.1773049645 | 14.1 | 26.16 | 5.99 | 122057 | 10.81629419 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
